|
[1]
|
Johnell, O., Kanis, J.A., Oden, A., et al. (2005) Predictive Value of BMD for Hip and Other Fractures. Journal of Bone & Mineral Research, 20, 1185-1194. [Google Scholar] [CrossRef]
|
|
[2]
|
Odén, A., Mccloskey, E.V., Kanis, J.A., et al. (2015) Burden of High Fracture Probability Worldwide: Secular Increases 2010-2040. Osteoporosis International, 26, 2243-2248. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Raska, J.I., Rasková, M., Zikán, V., et al. (2017) Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus. Central European Journal of Public Health, 25, 3-10. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
中华医学会. 原发性骨质疏松症基层诊疗指南(2019年) [J]. 中华全科医师杂志, 2020, 19(4): 304-315.
|
|
[5]
|
Lane, N.E. (2006) Epidemiology, Etiology, and Diagnosis of Osteoporosis. American Journal of Obstetrics & Gynecology, 194, S3-S11. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Cummings, S.R., Browner, W.S., Bauer, D., et al. (1998) Endogenous Hormones and the Risk of Hip and Vertebral Fractures among Older Women. The New England Journal of Medicine, 339, 733-738. [Google Scholar] [CrossRef]
|
|
[7]
|
Hannan, M.T., Felson, D.T., Dawson-Hughes, B., et al. (2000) Risk Factors for Longitudinal Bone Loss in Elderly Men and Women: The Framingham Osteoporosis Study. Journal of Bone & Mineral Research, 15, 710-720. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Mihara, M., Hashizume, M., Yoshida, H., et al. (2012) IL-6/IL-6 Receptor System and Its Role in Physiological and Pathological Conditions. Clinical Science, 122, 143-159. [Google Scholar] [CrossRef]
|
|
[9]
|
Chaabo, K. and Kirkham, B. (2015) Rheumatoid Arthritis—Anti-TNF. International Immunopharmacology, 27, 180-184. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Mori, T., Miyamoto, T., Yoshida, H., et al. (2011) IL-1β and TNFα-Initiated IL-6-STAT3 Pathway Is Critical in Mediating Inflammatory Cytokines and RANKL Expression in Inflammatory Arthritis. International Immunology, 23, 701-712. [Google Scholar] [CrossRef] [PubMed]
|